ARTICLE | Company News
OncoFusion Therapeutics, Medivation deal
January 25, 2016 8:00 AM UTC
OncoFusion will reacquire rights to its compounds targeting BET bromodomain proteins identified and developed with Medivation under a 2014 deal. OncoFusion said it plans to advance at least one compo...